SINCE its founding in 2016, Elon Musk’s neurotechnology company Neuralink has had the ambitious mission to build a next-generation brain implant with at least 100 times more brain connections than devices currently approved by the US Food and Drug Administration (FDA).
The company has now reached a significant milestone, having received FDA approval to begin human trials. So what were the issues keeping the technology in the pre-clinical trial phase for as long as it was? And have these concerns been addressed?
Neuralink is making a Class III medical device known as a brain-computer interface (BCI). The device connects the brain to an external computer via a Bluetooth signal, enabling continuous communication back and forth.
The device itself is a coin-sized unit called a Link. It’s implanted within a small disk-shaped cutout in the skull using a precision surgical robot. The robot splices a thousand tiny threads from the Link to certain neurons in the brain. Each thread is about a quarter the diameter of a human hair.
The company says the device could enable precise control of prosthetic limbs, giving amputees natural motor skills. It could revolutionise treatment for conditions such as Parkinson’s disease, epilepsy and spinal cord injuries. It also shows some promise for potential treatment of obesity, autism, depression, schizophrenia and tinnitus.
Several other neurotechnology companies and researchers have already developed BCI technologies that have helped people with limited mobility regain movement and complete daily tasks.
BCIs have also been used to help older people train their motor and cognitive abilities to moderate the worst effects of ageing.
In February 2021, Musk said Neuralink was working with the FDA to secure permission to start initial human trials later that year. But human trials didn’t commence in 2021.
Then, in March 2022, Neuralink made a further application to the FDA to establish its readiness to begin humans trials.
One year and three months later, on May 25 2023, Neuralink finally received FDA approval for its first human clinical trial. Given how hard Neuralink has pushed for permission to begin, we can assume it will begin very soon.
The approval has come less than six months after the US Office of the Inspector General launched an investigation into Neuralink over potential animal welfare violations.
The FDA had quite a list of issues that needed to be resolved before human trials could commence, as was reported in a Reuters investigation, which claimed to have spoken to several Neuralink sources.
Most of these concerns called for Neuralink to perform thorough and repeated testing and data collection over an extended period. This was likely a deciding factor in why the approval process to begin human testing took as long as it did.
It can’t be said with certainty that all of the issues have been fully resolved. But considering the rigour of the FDA’s approval process, we might conclude they have at least been resolved to a point of satisfaction for the FDA.
A precision robot known as Implant/r1 performs the surgical procedure to implant the Neuralink BCI. This robot surgeon had to be put through its paces to gather evidence that it could reliably and safely implant and remove the Neuralink BCI without damaging surrounding brain tissue, or creating the risk of infection, bleeding, inflammation or scarring.
Once implanted, the Neuralink BCI must function as intended. It must not unintentionally influence other brain functions, or cause any unwanted side effects such as seizures, headaches, mood changes, or cognitive impairment.
In particular, overheating lithium-ion batteries can pose great risk to BCI users. When defective, such batteries have historically been known to overheat. They can even explode if the insulation between the cathode and anode (the metal electrode components) breaks down, resulting in a short circuit.
The longevity of the battery was also taken into account, as well as how easy it would be to safely replace from its position under the skin behind the ear. Since the FDA’s previous rejection, extensive tests have been conducted on the specially designed Neuralink battery to evaluate its performance, durability and bio-compatibility.
Then there is the risk of wire migration. The Link consists of a disk-shaped chip with very thin wire electrodes that connect to neurons in the brain.
Connecting these wires by means of a surgical robot is a major challenge in itself. But there is also the possibility the electrodes could move elsewhere in the brain over time due to natural movement, inflammation, or scar tissue formation. This would likely affect the proper functioning of the device, and could cause infection or damage to the brain tissue.
Neuralink had to conduct extensive animal studies and provide evidence its wires did not migrate significantly over time, or cause any adverse effects on the brain. The company also had to show it had a method for tracking and adjusting the position of the wires if this became necessary.
Another challenge Neuralink faced was that of safe implant removal. The FDA wanted to know how easy or difficult it would be to remove the device from the brain if this became necessary.
Strong safeguards are required to prevent data collected by the Link from being hacked, manipulated or otherwise misused. Neuralink would have had to assure the FDA it could avoid nightmare scenarios of hackers rendering its Link users vulnerable to interference, as well as guaranteeing the privacy of brain-wave data generated by the device.
Critics acknowledge the potential benefits of Neuralink, but caution the company to hasten slowly. Adequately addressing these issues will take time – and corners must not be cut when arriving at a solution.
Beyond the Link’s potential medical uses, Musk has made many radical claims regarding his future vision for the technology. He has claimed Neuralink could augment human intelligence by creating an on-demand connection with artificial intelligence systems – allowing, for example, improved cognition through enhanced memory, and improved learning and problem-solving skills.
He has even gone as far as to say the Link could allow high-bandwidth telepathic communication between two or more people connected via a mediating computer. Common sense would suggest these claims be put in the “I’ll believe it when I see it” category.
The situation with Neuralink has clear parallels with current advancements in AI (and the growing need to regulate it). As exciting as these technologies are, they must not be released to the public until proven to be safe. This can only be achieved by exhaustive testing.
Reuters
Sat Jun 03 2023
Elon Musk has claimed Neuralink could augment human intelligence by creating an on-demand connection with artificial intelligence systems. - REUTERS/Filepic
Rwanda catat 7 lagi kes virus Marburg dan satu lagi kematian
Rwanda mencatatkan tujuh kes baharu penyakit virus Marburg dan satu lagi kematian.
Menurut angka terkini yang dikeluarkan lewat Rabu Kementerian Kesihatan Rwanda,
jumlah keseluruhan jangkitan virus Marburg sejak wabak bermula kini sebanyak 36 kes, dengan 11 kematian dilaporkan setakat ini.
Menurut angka terkini yang dikeluarkan lewat Rabu Kementerian Kesihatan Rwanda,
jumlah keseluruhan jangkitan virus Marburg sejak wabak bermula kini sebanyak 36 kes, dengan 11 kematian dilaporkan setakat ini.
Lebih 140 sekolah UNRWA diserang sejak 7 Oktober
Lebih 140 sekolah UNRWA diserang sejak 7 Oktober dalam keadaan dimana penduduk Gaza berlindung di bawah naungan PBB.
Perkara itu dimaklumkan Pesuruhjaya Agung Agensi Bantuan dan Kerja Pertubuhan Bangsa-Bangsa Bersatu untuk Pelarian Palestin (UNRWA) Philippe Lazzarini dalam satu hantaran di X.
Perkara itu dimaklumkan Pesuruhjaya Agung Agensi Bantuan dan Kerja Pertubuhan Bangsa-Bangsa Bersatu untuk Pelarian Palestin (UNRWA) Philippe Lazzarini dalam satu hantaran di X.
28 petugas dilapor maut dalam tempoh 24 jam lalu di Lubnan
28 petugas kesihatan dilaporkan terbunuh dalam tempoh 24 jam lalu di Lubnan.
Perkara itu dimaklumkan Ketua Pengarah Pertubuhan Kesihatan Sedunia (WHO) Tedros Adhanom Ghebreyesus pada Khamis.
Perkara itu dimaklumkan Ketua Pengarah Pertubuhan Kesihatan Sedunia (WHO) Tedros Adhanom Ghebreyesus pada Khamis.
UNIFIL kekal pada posisi walaupun didesak berundur
Pasukan pengaman PBB di selatan Lubnan terus bertahan pada kedudukan mereka, di bawah mandat UNSC, walaupun diarah Israel untuk berundur.
G7 desak pemain serantau di Asia Barat bertindak cermat dalam krisis
Pemimpin Kumpulan Tujuh (G7) mengulangi kebimbangan mereka terhadap krisis di Asia Barat dan menyeru pemain serantau supaya bertindak dengan bertanggungjawab serta berhemah.
Mereka turut menegaskan sokongan penuh terhadap keselamatan Israel.
Mereka turut menegaskan sokongan penuh terhadap keselamatan Israel.
AS sokong operasi Israel di Lubnan meski risiko meluaskan konflik
Pentadbiran Joe Biden menyatakan bahawa adalah wajar untuk Israel meneruskan serangan darat dan udara terhadap Hezbollah buat masa ini, menurut jurucakap Jabatan Negara Amerika Syarikat, Matthew Miller.
Namun, beliau mengakui risiko operasi di Lubnan mungkin melangkaui matlamat semasa Israel.
Namun, beliau mengakui risiko operasi di Lubnan mungkin melangkaui matlamat semasa Israel.
Politik stabil, dasar kerajaan tarik minat syarikat global melabur di Malaysia - Gobind
Menurut Menteri Digital Gobind Singh Deo, pada masa ini terdapat banyak perbincangan, tidak hanya antara syarikat-syarikat di negara serantau malah dunia berhubung perkara itu.
Lawatan negara Anwar ke Pakistan raih potensi perdagangan RM2.65 bilion - Tengku Zafrul
Pakistan turut beri komitmen untuk tingkat import minyak kelapa sawit dari Malaysia dan import produk berasaskan kayu, baja, petrokimia.
Tiada potensi penyelesaian diplomatik konflik Israel-Palestin
PM Anwar Ibrahim akui usaha diplomatik gagal hentikan kekejaman Israel di Palestin dan Lubnan, menyalahkan sokongan kuat dari Amerika Syarikat sebagai punca.
Malaysia dan Pakistan perkukuh kerjasama menentang ekstremisme
PM Anwar Ibrahim menyeru Malaysia dan Pakistan untuk memperhebat usaha bersama dalam memerangi keganasan melalui kerjasama risikan, strategi, dan pembaharuan pendidikan serta sosial.
Nilai X dilapor susut hampir 80% sejak dibeli Elon Musk
X dihantui pelbagai isu besar sejak Musk mengatakan ia adalah platform sebenar untuk kebebasan bersuara.
Mark Zukerberg catat nilai bersih pendapatan tertinggi
Mark Zuckerberg berpotensi menjadi orang terkaya di dunia selepas mencatat nilai bersih pendapatan paling tinggi tahun ini.
SpaceX kawal 62% satelit aktif di angkasa
Perkhidmatan internet Starlink ditawarkan di lebih 100 negara, termasuk Malaysia. Bergerak ke hadapan, lebih banyak satelit Starlink dijangka dilepaskan ke angkasa.
Brazil gantung X, akaun Starlink dibeku
Platform X diarah digantung sepenuhnya sehingga semua arahan mahkamah dipatuhi.
Mahkamah tertinggi Brazil ancam gantung operasi X di negara itu
Elon Musk diarah namakan seorang wakil undang-undang X di Brazil atau berhadapan tindakan digantung operasi media sosial itu.
Pengasas Telegram ditahan: Musk secara sinis ramal hukuman berat menjelang 2030 di Eropah
Musk dengan nada sinis meramalkan bahawa menjelang 2030, Eropah mungkin akan mula melaksanakan hukuman berat terhadap individu yang menyukai imej humor (meme) di internet.
Elon Musk, X disaman culas bayar syarikat pembekal mesin pelayan
Menurut Wiwynn, kontrak pembelian mesin pelayan dengan Twitter telah bermula sejak 2014 dan bernilai sekitar $120 juta dari segi komponen mesin pelayan yang dibeli.
Elon Musk sedia berkhidmat dalam kerajaan AS jika ditawarkan
Usahawan Amerika Syarikat (AS) Elon Musk pada Selasa menyatakan kesediaannya untuk berkhidmat dalam Kerajaan AS jika ditawarkan peranan sedemikian.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang hari ini.
Buli siber: Imane Khelif saman Elon Musk, JK Rowling
Elon dan JK Rowling dinamakan dalam aduan jenayah yang dihantar ke pusat anti kebencian di pejabat pendakwa raya umum minggu lepas.